FDA NDC Directory · JSON-LD · Markdown

Abiraterone

NDC 68001-489 · HUMAN PRESCRIPTION DRUG · TABLET

Generic nameAbiraterone acetate
Labeler / ManufacturerBluePoint Laboratories
Marketing categoryAbbreviated NDA (generic) · App ANDA210686
Dosage form / routeTABLET · ORAL
Active ingredientsABIRATERONE ACETATE (250 mg/1)
Marketing started20190710
Package count1

External sources

Source: openFDA. Public-domain (CC0).